Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 19.00
+0.70 (3.83%)
Sep 15, 2026, 1:56 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 601.6 million as of September 15, 2026. Its market cap has decreased by -45.58% in one year.
Market Cap
601.60M
Enterprise Value
719.56M
Revenue
170.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.00
ChartMarket Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 601.60M, a decrease of -66.11%. That is a compound annual growth rate of -17.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 601.60M | -53.66% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Preventive Medicine | 1.04B |
| Level Biotechnology | 1.02B |
| TCI GENE | 947.21M |
| GeneReach Biotechnology | 926.79M |
| NatureWise Biotech & Medicals | 867.37M |
| Meribank Biotech | 834.03M |
| Neith | 793.51M |
| BioLASCO Taiwan | 729.94M |